|
1
|
Giri S, Pathak R, Aryal MR, Karmacharya P,
Bhatt VR and Martin MG: Incidence trend of esophageal squamous cell
carcinoma: An analysis of Surveillance Epidemiology, and End
Results (SEER) database. Cancer Causes Control. 26:159–161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin Y, Totsuka Y, Shan B, Wang C, Wei W,
Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in
high-risk areas of China: Research progress and challenges. Ann
Epidemio. 27:215–221. 2017. View Article : Google Scholar
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Diederichs S, Bäumer N, Ji P, Metzelder
SK, Idos GE, Cauvet T, Wang W, Möller M, Pierschalski S, Gromoll J,
et al: Identification of interaction partners and substrates of the
cyclin A1-CDK2 complex. J Biol Chem. 279:33727–33741. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji P, Agrawal S, Diederichs S, Bäumer N,
Becker A, Cauvet T, Kowski S, Beger C, Welte K, Berdel WE, et al:
Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell
cycle progression in somatic cells. Oncogene. 24:2739–2744. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Müller-Tidow C, Ji P, Diederichs S,
Potratz J, Bäumer N, Köhler G, Cauvet T, Choudary C, van der Meer
T, Chan WY, et al: The cyclin A1-CDK2 complex regulates DNA
double-strand break repair. Mol Cell Biol. 24:8917–8928. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rivera A, Mavila A, Bayless KJ, Davis GE
and Maxwell SA: Cyclin A1 is a p53-induced gene that mediates
apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian,
and lung carcinoma cells. Cell Mol Life Sci. 63:1425–1439. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang R, Müller C, Huynh V, Fung YK, Yee AS
and Koeffler HP: Functions of cyclin A1 in the cell cycle and its
interactions with transcription factor E2F-1 and the Rb family of
proteins. Mol Cell Biol. 19:2400–2407. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Matzuk MM, Sung WK, Guo Q, Wang P
and Wolgemuth DJ: Cyclin A1 is required for meiosis in the male
mouse. Nat Genet. 20:377–380. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krämer A, Hochhaus A, Saussele S, Reichert
A, Willer A and Hehlmann R: Cyclin A1 is predominantly expressed in
hematological malignancies with myeloid differentiation. Leukemia.
12:893–898. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang B, Miao S, Zhang LN, Sun HB, Xu ZN
and Han CS: Correlation of CCNA1 promoter methylation with
malignant tumors: A meta-analysis introduction. Biomed Res Int.
2015:1340272015.PubMed/NCBI
|
|
12
|
Yanatatsaneejit P, Chalermchai T,
Kerekhanjanarong V, Shotelersuk K, Supiyaphun P, Mutirangura A and
Sriuranpong V: Promoter hypermethylation of CCNA1, RARRES1, and
HRASLS3 in nasopharyngeal carcinoma. Oral Oncol. 44:400–406. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang N, Eijsink JJ, Lendvai A, Volders HH,
Klip H, Buikema HJ, van Hemel BM, Schuuring E, van der Zee AG and
Wisman GB: Methylation markers for CCNA1 and C13ORF18 are strongly
associated with high-grade cervical intraepithelial neoplasia and
cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers
Prev. 18:3000–3007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zuo Q, Zheng W, Zhang J, Pan Z, Liu Y,
Long H, Fan P, Guo C, Li F and Shao R: Methylation in the promoters
of HS3ST2 and CCNA1 genes is associated with cervical cancer in
Uygur women in Xinjiang. Int J Biol Markers. 29:e354–e362. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Müller C, Readhead C, Diederichs S, Dos G,
Yang R, Tidow N, Serve H, Berdel WE and Koeffler HP: Methylation of
the cyclin A1 promoter correlates with gene silencing in somatic
cell lines, while tissue-specific expression of cyclin A1 is
methylation independent. Mol Cell Biol. 20:3316–3329. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho NH, Choi YP, Moon DS, Kim H, Kang S,
Ding O, Rha SY, Yang YJ and Cho SH: Induction of cell apoptosis in
non-small cell lung cancer cells by cyclin A1 small interfering
RNA. Cancer Sci. 97:1082–1092. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chujan S, Kitkumthorn N, Siriangkul S and
Mutirangura A: CCNA1 promoter methylation: A potential marker for
grading Papanicolaou smear cervical squamous intraepithelial
lesions. Asian Pac J Cancer Prev. 15:7971–7975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Farhadieh RD, Smee R, Rees CG, Salardini
A, Eggleton S, Yang JL and Russell PJ: Mutant p53 and cyclin A1
protein expression in primary laryngeal squamous cell carcinomas do
not correlate to second primary tumours of the head and neck. ANZ J
Surg. 79:48–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weiss D, Koopmann M, Basel T and Rudack C:
Cyclin A1 shows age-related expression in benign tonsils,
HPV16-dependent overexpression in HNSCC and predicts lower
recurrence rate in HNSCC independently of HPV16. BMC Cancer.
12:2592012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang KC, Yang J, Ng MC, Ng SK, Welch WR,
Muto MG, Berkowitz RS and Ng SW: Cyclin A1 expression and
paclitaxel resistance in human ovarian cancer cells. Eur J Cancer.
67:152–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arsenic R, Braicu EI, Letsch A, Dietel M,
Sehouli J, Keilholz U and Ochsenreither S: Cancer-testis antigen
cyclin A1 is broadly expressed in ovarian cancer and is associated
with prolonged time to tumor progression after platinum-based
therapy. BMC Cancer. 15:7842015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klajic J, Busato F, Edvardsen H, Touleimat
N, Fleischer T, Bukholm I, Børresen-Dale AL, Lønning PE, Tost J and
Kristensen VN: DNA methylation status of key cell-cycle regulators
such as CDKNA2/p16 and CCNA1 correlates with treatment response to
doxorubicin and 5-fluorouracil in locally advanced breast tumors.
Clin Cancer Res. 20:6357–6366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union against Cancer (UICC) TNM classification of
malignant tumours. Wiley-Liss. (New York). 73–76. 2010.
|
|
24
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO Classification of Tumours of the digestic system.
(4th). (Lyon). IARC press. pp4172010.
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maziéres J, Brugger W, Cappuzzo F, Middel
P, Frosch A, Bara I, Klingelschmitt G and Klughammer B: Evaluation
of EGFR protein expression by immunohistochemistry using H-score
and the magnification rule: Re-analysis of the SATURN study. Lung
Cancer. 82:231–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Müller-Tidow C, Diederichs S, Schrader MG,
Vogt U, Miller K, Berdel WE and Serve H: Cyclin A1 is highly
expressed in aggressive testicular germ cell tumors. Cancer Lett.
190:89–95. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wennhold K, Theurich S and von
Bergwelt-Baildon M: Cyclin A1, a promising tumor antigen: The devil
is in the amino acids. Expert Rev Anticancer Ther. 13:243–245.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ochsenreither S, Majeti R, Schmitt T,
Stirewalt D, Keilholz U, Loeb KR, Wood B, Choi YE, Bleakley M,
Warren EH, et al: Cyclin-A1 represents a new immunogenic targetable
antigen expressed in acute myeloid leukemia stem cells with
characteristics of a cancer-testis antigen. Blood. 119:5492–5501.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Munari E, Chaux A, Maldonado L, Compérat
E, Varinot J, Bivalacqua TJ, Hoque MO and Netto GJ: Cyclin A1
expression predicts progression in pT1 urothelial carcinoma of
bladder: A tissue microarray study of 149 patients treated by
transurethral resection. Histopathology. 66:262–269. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wegiel B, Bjartell A, Tuomela J, Dizeyi N,
Tinzl M, Helczynski L, Nilsson E, Otterbein LE, Härkönen P and
Persson JL: Multiple cellular mechanisms related to cyclin A1 in
prostate cancer invasion and metastasis. J Natl Cancer Inst.
100:1022–1036. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ekberg J, Holm C, Jalili S, Richter J,
Anagnostaki L, Landberg G and Persson JL: Expression of cyclin A1
and cell cycle proteins in hematopoietic cells and acute myeloid
leukemia and links to patient outcome. Eur J Haematol. 75:106–115.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Holm C, Ora I, Brunhoff C, Anagnostaki L,
Landberg G and Persson JL: Cyclin A1 expression and associations
with disease characteristics in childhood acute lymphoblastic
leukemia. Leuk Res. 30:254–261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marlow LA, von Roemeling CA, Cooper SJ,
Zhang Y, Rohl SD, Arora S, Gonzales IM, Azorsa DO, Reddi HV, Tun
HW, et al: Foxo3a drives proliferation in anaplastic thyroid
carcinoma through transcriptional regulation of cyclin A1: A
paradigm shift that impacts current therapeutic strategies. J Cell
Sci. 125:4253–4263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hsia DA, Tepper CG, Pochampalli MR, Hsia
EY, Izumiya C, Huerta SB, Wright ME, Chen HW, Kung HJ and Izumiya
Y: KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1
coding region to regulate cancer cell proliferation. Proc Natl Acad
Sci USA. 107:9671–9676. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu Y, Huang Y and Zhu GZ: Cyclin A1 is a
transcriptional target of PITX2 and overexpressed in papillary
thyroid carcinoma. Mol Cell Biochem. 384:221–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wegiel B, Bjartell A, Culig Z and Persson
JL: Interleukin-6 activates PI3K/Akt pathway and regulates cyclin
A1 to promote prostate cancer cell survival. Int J Cancer.
122:1521–1529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wegiel B, Bjartell A, Ekberg J, Gadaleanu
V, Brunhoff C and Persson JL: A role for cyclin A1 in mediating the
autocrine expression of vascular endothelial growth factor in
prostate cancer. Oncogene. 24:6385–6393. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miftakhova R, Hedblom A, Semenas J,
Robinson B, Simoulis A, Malm J, Rizvanov A, Heery DM, Mongan NP,
Maitland NJ, et al: Cyclin A1 and P450 aromatase promote metastatic
homing and growth of stem-like prostate cancer cells in the bone
marrow. Cancer Res. 76:2453–2464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Syed Khaja AS, Dizeyi N, Kopparapu PK,
Anagnostaki L, Härkönen P and Persson JL: Cyclin A1 modulates the
expression of vascular endothelial growth factor and promotes
hormone-dependent growth and angiogenesis of breast cancer. PLoS
One. 8:e722102013. View Article : Google Scholar : PubMed/NCBI
|
